We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$3.46B
Cap. Flow %
-1.41%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.64%
2 Healthcare 14.1%
3 Financials 12.4%
4 Consumer Discretionary 12.19%
5 Communication Services 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRC
376
DELISTED
First Republic Bank
FRC
$97.4M 0.04%
919,322
+116,243
+14% +$11.9M
XYZ
377
Block Inc
XYZ
$47.5B
$97.2M 0.04%
926,266
+139,368
+18% +$10.7M
PAYX icon
378
Paychex
PAYX
$42.7B
$95.7M 0.04%
1,263,771
-76,648
-6% -$5.31M
EXAS
379
DELISTED
Exact Sciences
EXAS
$94.4M 0.04%
1,085,865
+340,334
+46% +$27.2M
MCHP icon
380
Microchip Technology
MCHP
$46B
$94.3M 0.04%
1,790,620
+107,008
+6% +$4.81M
ANSS
381
DELISTED
Ansys
ANSS
$93.8M 0.04%
321,661
+6,499
+2% +$1.73M
IPHI
382
DELISTED
INPHI CORPORATION
IPHI
$93.6M 0.04%
796,528
-141,777
-15% -$14.9M
CTSH icon
383
Cognizant
CTSH
$26B
$93.5M 0.04%
1,646,419
-460,792
-22% -$24.8M
UTHR icon
384
United Therapeutics
UTHR
$23.1B
$93.3M 0.04%
770,836
-5,577
-0.7% -$628K
BIDU icon
385
Baidu
BIDU
$37.2B
$93.1M 0.04%
776,443
-77,661
-9% -$8.31M
MOH icon
386
Molina Healthcare
MOH
$10.3B
$92.3M 0.04%
518,591
-8,924
-2% -$1.52M
MTD icon
387
Mettler-Toledo International
MTD
$28.6B
$91.7M 0.04%
113,801
+1,757
+2% +$1.31M
TFX icon
388
Teleflex
TFX
$5.98B
$90.9M 0.04%
249,855
-1,814
-0.7% -$627K
CDW icon
389
CDW
CDW
$17B
$90.9M 0.04%
782,650
-678,169
-46% -$73.5M
CBRE icon
390
CBRE Group
CBRE
$42.9B
$90.8M 0.04%
2,007,275
-558,061
-22% -$24.1M
DTE icon
391
DTE Energy
DTE
$29.1B
$90.5M 0.04%
989,036
-106,462
-10% -$9.42M
MXIM
392
DELISTED
Maxim Integrated Products
MXIM
$90.2M 0.04%
1,488,981
+66,911
+5% +$3.73M
EMR icon
393
Emerson Electric
EMR
$88.3B
$90M 0.04%
1,451,560
-55,069
-4% -$3.13M
WPC icon
394
W.P. Carey
WPC
$16.4B
$89.9M 0.04%
1,356,207
+200,080
+17% +$12.4M
HES
395
DELISTED
Hess
HES
$89.6M 0.04%
1,730,147
+113,661
+7% +$5.2M
CAH icon
396
Cardinal Health
CAH
$55.4B
$89.3M 0.04%
1,711,381
-70,702
-4% -$3.64M
CMI icon
397
Cummins
CMI
$88.7B
$89.2M 0.04%
514,546
-52,025
-9% -$8.31M
TROW icon
398
T. Rowe Price
TROW
$24.3B
$89.1M 0.04%
721,850
-89,879
-11% -$10.2M
HR icon
399
Healthcare Realty
HR
$6.84B
$88.4M 0.04%
3,331,747
+1,139,767
+52% +$29.2M
TCOM icon
400
Trip.com Group
TCOM
$29.1B
$88M 0.04%
3,393,739
+155,633
+5% +$3.92M

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.